UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000045346 |
|---|---|
| Receipt number | R000047554 |
| Scientific Title | Study on cancer patient parameters. |
| Date of disclosure of the study information | 2021/09/02 |
| Last modified on | 2021/09/02 07:16:39 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
KUMAMON cancer registry
Acronym
KUMAMON cancer registry
Scientific Title
Study on cancer patient parameters.
Scientific Title:Acronym
Study on cancer patient parameters.
Region
| Japan |
Condition
Condition
malignant disease
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The progress in cancer treatment has been remarkable, and in addition to surgical treatment, chemotherapy with various targeted drugs and new radiation therapy have been developed, and the survival rate of cancer patients has been greatly improved. Along with this, there are some reports that the onset of cardiovascular disease affects the prognosis of cancer patients.
Basic objectives2
Others
Basic objectives -Others
Currently, studies are underway to identify new biomarkers for the pathogenesis of cardiovascular disease such as arteriosclerosis and coronary artery disease in cancer patients. This time, in this study, diagnosis of various cardiovascular diseases (ischemic heart disease/peripheral artery disease, cardiomyopathy, heart failure, arrhythmia, valvular heart disease, aortic aneurysm, aortic dissection, venous thrombosis), determination of severity and therapeutic effect, We will search for biomarkers that can be prognostic and examine their usefulness.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
all cause mortality
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 1 | years-old | <= |
Age-upper limit
| 120 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Cancer patients who are registered in the Cancer Registration Section of our hospital.
Key exclusion criteria
none
Target sample size
35000
Research contact person
Name of lead principal investigator
| 1st name | Daisuke |
| Middle name | |
| Last name | Sueta |
Organization
Kumamoto University
Division name
Cardiovascular Medicine
Zip code
860-8556
Address
1-1-1, Honjo, Kumamoto
TEL
096-373-5175
sueta-d@kumamoto-u.ac.jp
Public contact
Name of contact person
| 1st name | Daisuke |
| Middle name | |
| Last name | Sueta |
Organization
Kumamoto University
Division name
Cardiovascular Medicine
Zip code
860-8556
Address
1-1-1, Honjo, Kumamoto
TEL
096-373-5175
Homepage URL
sueta-d@kumamoto-u.ac.jp
Sponsor or person
Institute
Kumamoto University
Institute
Department
Personal name
Funding Source
Organization
self-funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kumamoto University
Address
1-1-1, Honjo, Kumamoto
Tel
096-373-5175
sueta-d@kumamoto-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 09 | Month | 02 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Suspended
Date of protocol fixation
| 2021 | Year | 09 | Month | 01 | Day |
Date of IRB
| 2020 | Year | 02 | Month | 20 | Day |
Anticipated trial start date
| 2021 | Year | 10 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
observation study
Management information
Registered date
| 2021 | Year | 09 | Month | 02 | Day |
Last modified on
| 2021 | Year | 09 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047554
